In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

Vaccine

Volumn 14, Issue 15, 1996, Pages 1412-1416

  Gupta, Rajesh K ^a   Chang, An Cheng ^a   Griffin, Paul ^a   Rivera, Rachel ^a   Siber, George R ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aluminium phosphate; Distribution; Microspheres; Radioactivity; Tetanus toxoid

Indexed keywords

CARBON 14; MICROSPHERE; POLYMER; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; KIDNEY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BIOCOMPATIBLE MATERIALS; CARBON RADIOISOTOPES; DELAYED-ACTION PREPARATIONS; FEMALE; IMMUNOGLOBULIN G; KIDNEY; LACTIC ACID; LYMPH NODES; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; TETANUS TOXOID;

EID: 0030460025     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00073-4     Document Type: Article

References (22)

1. 1 Morris, W., Steinhoff, M.C. and Russell, P.K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994, 12, 5-11
2. 2 Hanes, J., Chiba, M. and Langer, R. Polymer microspheres for vaccine delivery. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 389-412
3. 3 Gupta, R.K. and Siber, G.R. Adjuvants for human use - current status, problems and future prospects. Vaccine 1995, 13, 1263-1276
4. 4 Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S. and Gupta, C.K. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 1993, 11, 293-306
5. 5 Alonso, M.J., Cohen, S., Park, T.G., Gupta, R.K., Siber, G.R. and Langer, R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharmaceut. Res. 1993, 10, 945-953
6. 6 Alonso, M.J., Gupta, R.K., Min, C., Siber, G.R. and Langer, R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994, 12, 299-306
7. 7 Yan, C., Resau, J.H., Hewetson, J., West, M., Rill, W.L. and Kende, M. Characterization and morphological analysis of protein-loaded poly (lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. J. Controlled Rel. 1994, 32, 231-241
8. 8 Okada, H., Doken, Y., Ogawa, Y. and Toguchi, H. Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs. Pharmaceut. Res. 1994, 11, 1199-1203
9. 9 Okada, H., Yamamoto, M. and Heya, T. et al. Drug delivery using biodegradable microspheres. J. Controlled Rel. 1994, 28, 121-129
10. 10 Asano, M., Yoshida, M. and Omichi, H. et al. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system. Biomaterials 1993, 14, 797-799
11. 11 Dawson, D.J. and Mauritzen, C.M. Studies on tetanus toxin and toxoid. IV. Interaction of formaldehyde with tetanus toxin. Aust. J. Biol. Sci. 1969, 22, 1217-1227
12. 12 Gupta, R.K. and Siber, G.R. Comparison of adjuvant activities of aluminum phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 1994, 22, 53-63
13. 13 Chang, A.-C. and Gupta, R.K. Stabilization of tetanus toxoid in poly (dl-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharmaceut. Sci. 1996, 85, 129-132
14. 14 Latham, W.C., Rost, B. and Campbell, L. Tetanus toxoid: "Reversion" or residual toxicity? In: Proceedings of an Informal Consultation on the World Health Organization Requirements for Diphtheria, Tetanus, Pertussis and Combined Vaccines (Ed. Manclark, C.R.). Department of Health and Human Services, United States Public Health Service, Food and Drug Administration, Bethesda, MD, DHHS Publication No. (FDA) 91-1174, 1991, pp. 12-14
15. 15 Glenny, A.T., Buttle, G.A.H. and Stevens, M.F. Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: toxoid precipitated with alum. J. Pathol. Bacteriol. 1931, 34, 267-275
16. 16 Holt, L.B. Developments in Diphtheria Prophylaxis. Heinemann Medical Books, London, 1950, pp. 1-181
17. 17 Gupta, R.K., Rost, B.E., Relyveld, E. and Siber, G.R. Adjuvant properties of aluminum and calcium compounds. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 229-248
18. 18 Visscher, G.E., Robinson, R.L., Maulding, H.V., Fong, J.W., Pearson, J.E. and Argentieri, G.J. Biodegradation of and tissue reaction to 50:50 poly(dl-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 1985, 19, 349-365
19. 19 Gupta, R.K. and Relyveld, E.H. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine. Vaccine 1991, 9, 699-702
20. 14C-savoxepine loaded poly(d,l-lactic acid) nanospheres to rats. J. Controlled Rel. 1994, 29, 97-104
21. 21 Eldridge, J.H., Staas, J.K., Meulbroek, J.A., McGhee, J.R., Tice, T.R. and Gilley, R.M. Biodegradable microspheres as a vaccine delivery system. Molec. Immun. 1991, 28, 287-294
22. 22 Gupta, R.K. New advances in vaccine technologies and applications (meeting report). Vaccine 1995, 13, 1623-1625